FlandersBio on Twitter

Follow us on Twitter

Life sciences database

Databank life sciences

in het nederlands in english

FlandersBio offers an up-to-date life sciences database with detailed information about all FlandersBio members.

FlandersBio beschikt over een geüpdate life sciences databank met een gedetailleerd overzicht van alle FlandersBio-ledenbedrijven.

Oblita Therapeutics

Website: http://www.oblitatherapeutics.com
Phone: +32 4 75 27 40 98
FlandersBio Member
More address details

Business Focus

Oblita Therapeutics is a global health research & development start-up company. Our goal is to close current therapeutic gaps and improve the quality of life of those suffering from “forgotten” (neglected) diseases. Oblita Therapeutics’ lead program is focused on the development of a new drug (D121) to treat leishmaniasis (starting phase II). We have convincing preclinical results on the effectiveness of D121 against Cryptosporidium Parvum infection, Chagas Disease, and Fungal Infections.


More info

Address: Rodendijk 40
2980 Zoersel

Route: Via Google Maps
Website: http://www.oblitatherapeutics.com

Phone: +32 4 75 27 40 98
Foundation date: 3/2016
Email: caroline.jansen@oblita.be

Become a Member

Listen to some testimonials from companies that are a member of FlandersBio and discover the benefits of membership

Read more

Z Life Sciences

Looking behind the scenes of the vibrant life sciences sector in Flanders!



Belgian biotech on Euronext

Belgian biotech on Euronext

FlandersBio Members

MINT Europe Emtex Confluence Consulting CoBioRes trinean Bayer CropScience Talentmark UCare DROIA KU Leuven - Experimental Genetics Group Amakem Therapeutics GlobalYeast Belgium Mercuri Urval KU Leuven Pfizer SVR-ARCHITECTS MPCA (Medical and Pharmaceutical Consultancy and Applications) Abolins Viziphar Biosciences Q People Deloitte Gimv Balans Laboratorium eTheRNA Panaxea SilveRNA Right Away NonStop Recruitment KBC Securities Scannexus

View all members

Life Sciences Map

Life Sciences Map

View Life Sciences Map

Back to top